Who Will Control The EU’s Medicine Security?
“Investment in medicine security is like an insurance policy against a crisis. It is worth having, not only at the EU level but also at the national level. It does, however, require investment. This would strengthen not only medicine security but also the innovative economy”, says Sebastian Szymanek, CEO of Polpharma